List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Recombinant Therapeutic Protein Product Introduction
1.2 Global Recombinant Therapeutic Protein Outlook 2017 VS 2022 VS 2028
1.2.1 Global Recombinant Therapeutic Protein Sales in US$ Million for the Year 2017-2028
1.2.2 Global Recombinant Therapeutic Protein Sales in Volume for the Year 2017-2028
1.3 United States Recombinant Therapeutic Protein Outlook 2017 VS 2022 VS 2028
1.3.1 United States Recombinant Therapeutic Protein Sales in US$ Million for the Year 2017-2028
1.3.2 United States Recombinant Therapeutic Protein Sales in Volume for the Year 2017-2028
1.4 Recombinant Therapeutic Protein Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Recombinant Therapeutic Protein in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Recombinant Therapeutic Protein Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Recombinant Therapeutic Protein Market Dynamics
1.5.1 Recombinant Therapeutic Protein Industry Trends
1.5.2 Recombinant Therapeutic Protein Market Drivers
1.5.3 Recombinant Therapeutic Protein Market Challenges
1.5.4 Recombinant Therapeutic Protein Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Recombinant Therapeutic Protein Market Segment by Type
2.1.1 Recombinant Human Collage
2.1.2 Recombinant Human Serum Albumin
2.2 Global Recombinant Therapeutic Protein Market Size by Type
2.2.1 Global Recombinant Therapeutic Protein Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Recombinant Therapeutic Protein Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Recombinant Therapeutic Protein Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Recombinant Therapeutic Protein Market Size by Type
2.3.1 United States Recombinant Therapeutic Protein Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Recombinant Therapeutic Protein Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Recombinant Therapeutic Protein Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Recombinant Therapeutic Protein Market Segment by Application
3.1.1 Medicine
3.1.2 Scientific Research
3.1.3 Others
3.2 Global Recombinant Therapeutic Protein Market Size by Application
3.2.1 Global Recombinant Therapeutic Protein Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Recombinant Therapeutic Protein Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Recombinant Therapeutic Protein Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Recombinant Therapeutic Protein Market Size by Application
3.3.1 United States Recombinant Therapeutic Protein Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Recombinant Therapeutic Protein Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Recombinant Therapeutic Protein Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Recombinant Therapeutic Protein Competitor Landscape by Company
4.1 Global Recombinant Therapeutic Protein Market Size by Company
4.1.1 Top Global Recombinant Therapeutic Protein Manufacturers Ranked by Revenue (2021)
4.1.2 Global Recombinant Therapeutic Protein Revenue by Manufacturer (2017-2022)
4.1.3 Global Recombinant Therapeutic Protein Sales by Manufacturer (2017-2022)
4.1.4 Global Recombinant Therapeutic Protein Price by Manufacturer (2017-2022)
4.2 Global Recombinant Therapeutic Protein Concentration Ratio (CR)
4.2.1 Recombinant Therapeutic Protein Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Therapeutic Protein in 2021
4.2.3 Global Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Recombinant Therapeutic Protein Manufacturing Base Distribution, Product Type
4.3.1 Global Recombinant Therapeutic Protein Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Recombinant Therapeutic Protein Product Type
4.3.3 Date of International Manufacturers Enter into Recombinant Therapeutic Protein Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Recombinant Therapeutic Protein Market Size by Company
4.5.1 Top Recombinant Therapeutic Protein Players in United States, Ranked by Revenue (2021)
4.5.2 United States Recombinant Therapeutic Protein Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Recombinant Therapeutic Protein Sales by Players (2020, 2021 & 2022)
5 Global Recombinant Therapeutic Protein Market Size by Region
5.1 Global Recombinant Therapeutic Protein Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Recombinant Therapeutic Protein Market Size in Volume by Region (2017-2028)
5.2.1 Global Recombinant Therapeutic Protein Sales in Volume by Region: 2017-2022
5.2.2 Global Recombinant Therapeutic Protein Sales in Volume Forecast by Region (2023-2028)
5.3 Global Recombinant Therapeutic Protein Market Size in Value by Region (2017-2028)
5.3.1 Global Recombinant Therapeutic Protein Sales in Value by Region: 2017-2022
5.3.2 Global Recombinant Therapeutic Protein Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Recombinant Therapeutic Protein Market Size YoY Growth 2017-2028
6.1.2 North America Recombinant Therapeutic Protein Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Recombinant Therapeutic Protein Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Recombinant Therapeutic Protein Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Recombinant Therapeutic Protein Market Size YoY Growth 2017-2028
6.3.2 Europe Recombinant Therapeutic Protein Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Recombinant Therapeutic Protein Market Size YoY Growth 2017-2028
6.4.2 Latin America Recombinant Therapeutic Protein Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Recombinant Therapeutic Protein Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Recombinant Therapeutic Protein Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Corporation Information
7.1.2 Boehringer Ingelheim Description and Business Overview
7.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Products Offered
7.1.5 Boehringer Ingelheim Recent Development
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporation Information
7.2.2 Bristol-Myers Squibb Description and Business Overview
7.2.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Products Offered
7.2.5 Bristol-Myers Squibb Recent Development
7.3 Celldex Therapeutics
7.3.1 Celldex Therapeutics Corporation Information
7.3.2 Celldex Therapeutics Description and Business Overview
7.3.3 Celldex Therapeutics Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Products Offered
7.3.5 Celldex Therapeutics Recent Development
7.4 Eli Liily
7.4.1 Eli Liily Corporation Information
7.4.2 Eli Liily Description and Business Overview
7.4.3 Eli Liily Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Eli Liily Recombinant Therapeutic Protein Products Offered
7.4.5 Eli Liily Recent Development
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporation Information
7.5.2 GlaxoSmithKline Description and Business Overview
7.5.3 GlaxoSmithKline Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Products Offered
7.5.5 GlaxoSmithKline Recent Development
7.6 Merck
7.6.1 Merck Corporation Information
7.6.2 Merck Description and Business Overview
7.6.3 Merck Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Merck Recombinant Therapeutic Protein Products Offered
7.6.5 Merck Recent Development
7.7 Novartis
7.7.1 Novartis Corporation Information
7.7.2 Novartis Description and Business Overview
7.7.3 Novartis Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Novartis Recombinant Therapeutic Protein Products Offered
7.7.5 Novartis Recent Development
7.8 Regeneron Pharmaceuticals
7.8.1 Regeneron Pharmaceuticals Corporation Information
7.8.2 Regeneron Pharmaceuticals Description and Business Overview
7.8.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Products Offered
7.8.5 Regeneron Pharmaceuticals Recent Development
7.9 Roche
7.9.1 Roche Corporation Information
7.9.2 Roche Description and Business Overview
7.9.3 Roche Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Roche Recombinant Therapeutic Protein Products Offered
7.9.5 Roche Recent Development
7.10 Takeda
7.10.1 Takeda Corporation Information
7.10.2 Takeda Description and Business Overview
7.10.3 Takeda Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Takeda Recombinant Therapeutic Protein Products Offered
7.10.5 Takeda Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Recombinant Therapeutic Protein Industry Chain Analysis
8.2 Recombinant Therapeutic Protein Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Recombinant Therapeutic Protein Distributors
8.3 Recombinant Therapeutic Protein Production Mode & Process
8.4 Recombinant Therapeutic Protein Sales and Marketing
8.4.1 Recombinant Therapeutic Protein Sales Channels
8.4.2 Recombinant Therapeutic Protein Distributors
8.5 Recombinant Therapeutic Protein Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
